NuProbe

Boston, United States

NuProbe is a cutting-edge genomics and molecular diagnostics company.

$50.0M raised

Jun 2022

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NuProbe raised?

NuProbe has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in June 2022.

Who are NuProbe's investors?

NuProbe's investors include HSG, Pan-Lin Capital, Pappas Capital, Yonghua Capital, WuXi AppTec.

Where is NuProbe headquartered?

NuProbe is headquartered in Boston, United States.

What does NuProbe do?

NuProbe is a cutting-edge genomics and molecular diagnostics company.

What stage is NuProbe at?

NuProbe is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 2, 2022.

MLA

"NuProbe — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/nuprobe. Accessed July 2, 2026.

APA

VCBacked. (2022). NuProbe — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nuprobe

Wikipedia (cite web)

{{cite web |title=NuProbe — Funding & Investors |url=https://www.vcbacked.co/company/nuprobe |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 2, 2022.